Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Signal, Image and Video Processing|November 1, 2021
Frequency-domain loss function for deep exposure correction of dark imagesOjasvi Yadav, Koustav Ghosal, Sebastian Lutz, et al.
Infection and Drug Resistance|August 22, 2014
Comparative analysis of the infectivity rate of both Borrelia burgdorferi and Anaplasma phagocytophilum in humans and dogs in a New Jersey communityAndrea Gaito, Vedrana Gjivoje, Sebastian Lutz, et al.
Applied Clinical Informatics|March 12, 2025
Comprehensive Course on Clinical Study Data Management for Medical Informatics StudentsYevgeniia Ignatenko, Natalia Ortmann, Sebastian Lutz, et al.
Targeted Oncology|November 28, 2024
Unveiling the Digital Evolution of Molecular Tumor BoardsSebastian Lutz, Alicia D'Angelo, Sonja Hammerl, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 27, 2017
An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated CytotoxicityTim Wirt, Sophia Rosskopf, Thies Rösner, et al.
Frontiers in Immunology|July 5, 2022
Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage DisplaySteffen Krohn, Ammelie Svea Boje, Carina Lynn Gehlert, et al.
Cell Reports|August 4, 2024
Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1Alexander Muik, Jasmin Quandt, Bonny Gaby Lui, et al.
Antibodies (Basel, Switzerland)|November 20, 2020
Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-EngineeringSophia Roßkopf, Klara Marie Eichholz, Dorothee Winterberg, et al.
Biological Chemistry|October 30, 2021
Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigenChristian Kellner, Sebastian Lutz, Hans-Heinrich Oberg, et al.
Frontiers in Immunology|November 15, 2023
Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cellsSebastian Lutz, Katja Klausz, Anca-Maria Albici, et al.
Pageof 2